Furthermore, risk alleles in ARID5B and GATA3 were found to be more frequent among Hispanic Americans than in European Americans [8,9], consistent with ancestry-related disparities in ALL susceptibility and treatment outcomes. This evidence concerns the gene ARID5B and acute lymphoblastic leukemia.